Quantitative responses of serum folate to increasing intakes of folic acid in healthy women

European Journal of Clinical Nutrition

Volumn 51, Issue 12, 1997, Pages 839-845

  Truswell, A S ^a   Kounnavong, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Assessment of nutrient intake; Biomarker; Folic acid supplements; Red cell folate; Serum folate

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG ERYTHROCYTE LEVEL; ENZYME ASSAY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN;

EID: 0030859566     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600493     Document Type: Article

References (31)

1. Allman MA, Truswell AS, Stewart PM, Yau DF, Tiller DJ, Horvath JS, Duggan GG, Hall BM (1989): Vitamin supplementation of patients receiving haemodialysis. Med. J. Austral. 150, 130-133.
2. Anonymous (1995): Acid folique et grossesse. Societe francaise de pediatrie Comite de nutrition. Arch. de Pediatrie. 2, 173-181.
3. Bouskey CJ, Beresford SAA, Omenn GS & Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
4. Bower C (1996): Folate and the prevention of birth defects. Austral. J. Nutr. Diet. 53, S5-S8.
5. Burlingame BA, Milligan GC, Apimerica DE & Arthur JM (1993): The Concise New Zealand Food Composition Tables. New Zealand Institute for Crop and Food Research, Palmerston North.
6. Centers for Disease Control (1992): Recommendations for the use of folic acid to reduce the number of spina bifida and other neural tube defects. MMWR Morb. Mortal. Wkly. Rep. 41, 1-7.
7. Cravo ML, Fidalgo P, Pereira AD, Gouveia-Oliveira A, Selhub CP & Mason JB (1994): DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur. J. Cancer Prev.3, 473-479.
8. Czeizel A & Dudas I (1992): Prevention of first occurrence of neural tube defects by periconceptual vitamin supplementation. New Eng. J. Med.321, 1832-1835.
9. Expert Advisory Group (1992): Folic Acid and the Prevention of Neural Tube Defects. London, UK: Department of Health.
10. Food and Drug Administration, USA (1996): Press release, 29 February.
11. Gibson RS (1990): Principles of Nutritional Assessment. New York and Oxford: Oxford University Press, pp 464.
12. Giovanucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D & Roser BA (1993): Folate, methionine and alcohol intake and risk of colorectal adenoma. J. Natl. Cancer Inst. 85, 875-883.
13. Gregory JF (1995) The bioavailability of folate. In Folate in Health and Disease, ed LB Bailey, pp 195-235. New York and Basel: Marcel Dekker.
14. Health and Welfare Canada (1993): Issues: Folic Acid, the Vitamin that helps Protect against Neural Tube (Birth) Defects. Ottawa: Health Protection Branch.
15. Herbert V (1962): Experimental nutritional folate deficiency m man. Trans Assoc. Am. Physicians.75, 307-320.
16. Holland B, Welch AA, Unwin ID, Buss DA, Paul AA & Southgate DAT (1991): McCance and Widdowson's The Composition of Foods, 5th ed. Cambridge: Royal Society of Chemistry.
17. Kohlmeier L (1995): Future of dietary exposure assessment. Am. J. Clin. Nutr. 61 (suppl): 702S-709S.
18. Leece EA, Truswell AS, Elzerman H, Choudhury N & Ahmad ZI (1996): Relation between serum folate and folate intake in women. Proc. Nutr. Soc. Australia 19, 126.
19. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR (1996): Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA. 93, 3704-3709.
20. Medical Research Council Vitamin Study Research Group (1991): Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 338, 131-137.
21. Mooij PNM, Steegers-Thennissen RPM, Thomas CMG, Doesburg MH & Eskes TKAB (1993): Periconceptual vitamin profiles are not suitable for identifying women at risk for neural tube defects. J. Nut. 123, 197-203.
22. Morrison HI, Schaubel D, Desmenles M & Wigle DT (1996): Serum folate and risk of fatal coronary heart disease. JAMA 275, 1893-1896.
23. National Health and Medical Research Council (1995): Folate Fortification. Report of the Expert Panel on Folate Fortification. Canberra: Australian Government Publishing Service.
24. Phillips DR & Wright AJA (1982): Studies on the response of Lactobacillus casei to different folate monoglutamates. Br. J. Nutr. 47, 183-189.
25. Raiten DJ & Fisher KD (eds) (1994): Assessment of Folate Methodology Used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). Bethesda MD, USA: Life Sciences Research Office, Federation of American Societies for Experimental Biology.
26. Sauberlich HE, Dowdy RP & Skala JH (1974): Laboratory Tests for the Assessment of Nutritional Status. Cleveland, Ohio: CRC Press.
27. Scheelings P (1996): Prospects for measuring folates in Australian foods. Austral. J. Nutr. Diet 53 S23-S28.
28. Staatstoezicht op de Volksgesondheid (1993): Preventie neuraalbuis defecten. Rijswijk, 19 November.
29. Truswell AS (1996): Prospects for folic acid fortification and its monitoring. Austral. J. Nutr. Diet 53, S17-S23.
30. Tsui JC & Nordstrom JW (1990): Folate status of adolescents: effect of folic acid supplementation. J. Am. Diet Assn. 90, 1551-1556.
31. Von der Porten AE, Gregory JS, Toth JP, Cerda JJ, Curry SK & Bailey LB (1992): In vivo folate kinetics during chronic supplementation of human subjects with deuterium-labelled folic acid. J Nutr. 122, 1293-1299.